A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the Long-Acting Injectable of MK-5720 in Participants With Schizophrenia
Latest Information Update: 06 Mar 2025
At a glance
Most Recent Events
- 26 Mar 2024 Status changed from recruiting to completed.
- 21 Sep 2023 Status changed from not yet recruiting to recruiting.
- 28 Aug 2023 MK-8189 oral tablet added as a study drug in period 1. For period 2, 2 more primary end-points added.